“TO BE OR NOT TO BE” GWAS Ends the Controversy about the DRD2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)

Abstract excerpt

Since 1990, there have been thousands of published studies on addiction psychiatry. Several from Blum et al showed the clinical relevance of the Genetic Addiction Risk Severity (GARS) test in identifying risk for reward deficiency behaviors in cohorts from polysubstance abuse and pain clinics, post-surgical bariatrics, and DWI offenders facing prison time. Since Blum et al first published in JAMA (1990)...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Attention Deficit Hyperactivity Disorder
• Share to Neurotransmitter Receptor Influence on Behavior
• Share to Substance Abuse Treatment and Outcomes